Personalized Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

我是写那种格式的摘要比较好？

79 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

摘要一般有什么要求？

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2020-03-30 红土之王

这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表::
接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表:
杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章

mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章

178 0

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2019-10-10 mgn6022_62675333

审稿速度:12.0 | 投稿命中率:50.0
经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章

177 0

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2018-12-18 1222ec6bm09暂无昵称

可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表::
请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:
请问这个杂志收版面费吗？

187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？

210 0

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2018-10-06 122c6d6cm93(暂无昵称)

请问这个杂志收版面费吗？

222 0

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2018-06-25 huihuiswd

我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？

268 0

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2017-03-23 changer11

投了之后就后悔了，年文章才48篇，进了神坑

338 0

[GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审，大概多长时间？mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章mgn6022_62675333 2019-10-10 12:52:00 发表: 杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率：约50% 审稿时间：约12个月杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志不收费，但是审稿效率非常非常慢，去年投的文章，过了一年终于到校样环节了，续后发表还不知道是什么时候；适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ 187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表: 请问这个杂志收版面费吗？ , beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine，3周了，一直显示under consideration。我这个状态是不是还没外审啊，后续这个期刊还会不会出现Under Review等一般期刊的常用语吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了，年文章才48篇，进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]

2014-09-23 zjuliew

审稿速度:1.0 | 投稿命中率:75.0
经验分享：原来投了他一个系列的杂志叫biomarkers in medicine，编辑说该pm可以考虑，考虑了几天，还是接受了，说来这杂志的所谓PM概念还是蛮吸引人的，怎么if就那么低呢，不应该啊，可能是每年文章太少了吧，我也见过发了好多hepatology和JH的大牛在上面发社论的，不知道了，随便说说

330 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务